Cell-free DNA concentration in pleural fluid and serum: Quantitative approach and potential prognostic factor in patients with cancer and pleural effusions

Clinical Lung Cancer

Volumn 8, Issue 2, 2006, Pages 140-145

  Benlloch, Susana ^a   Martí Ciriquián, Juan Luis ^a   Galbis Caravajal, José Marcelo ^b   Martín, Concepción ^a   Sánchez Payá, José ^a   Rodríguez Paniagua, José Manuel ^a   Romero, Santiago ^a   Massutí, Bartomeu ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b HOSPITAL DE LA RIBERA   (Spain)

Author keywords

Biologic assay; Diagnosis; Disease progression; DNA quantification; Real time polymerase chain reaction; Tumor markers

Indexed keywords

DNA; RIBONUCLEASE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER SURVIVAL; CELL FREE SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL COMPUTING; PLEURA EFFUSION; PLEURA FLUID; PROGNOSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SURVIVAL TIME;

EID: 33750190059     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2006.n.043     Document Type: Article

References (20)

1. Sahn S. State of the art. The pleura. Am Rev Respir Dis 1988; 138:184-234.
2. Sahn S. Malignancy metastatic to the pleura. Clin Chim Acta 1998; 19:351-361.
3. Light RW. Malignant pleural effusions. In: Light RW, ed. Pleural Diseases. Baltimore, MD: Williams & Williams; 1995.
4. Antony VE, Loddenkemper R, Astoul P, et al. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000; 162:1987-2001.
5. Miédougé M, Rouzaud P, Salama G, et al. Evaluation of seven tumors markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer 1999; 81:1059-1065.
6. Ferrer JS, Muñoz XG, Orriols RM et al. Evolution of idiopathic pleural efFusion: a prospective, long-term follow-up study. Chest 1996; 109:1508-1513.
7. Hung TL, Chen FF, Liu JM, et al. Clinical evaluation of HER2/neu protein in malignant pleural effusion-associated lung adenocarcinomas and as a tumor marker in pleural effusion diagnosis. Clin Cancer Res 2003; 9:2605-2612.
8. Romero S, Fernandez C, Arriero JM, et al. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions. Eur Respir J 1996; 9:17-23.
9. Bunn PA Jr. Early detection of lung cancer using serum RNA or DNA markers: ready for "prime time" or for validation? J Clin Oncol 2003; 21:3891-3893.
10. Villena V, Lopez-Encuentra A, Echave-Susaeta J, et al. Diagnostic value of CA-72-4, carcinoembryonic antigen, CA 15-3 and CA 19-9 assay in pleural fluid. A study of 207 patients. Cancer 1996; 78:736-740.
11. Shapiro B, Chakrabarry M, Cohn EM. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 1983; 51:2116-2120.
12. Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977; 37:646-650.
13. Sozzi G, Conte D, Mariani L, et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 2001; 61:4675-4678.
14. Ramirez JL, Sarries C, de Castro PL, et al. Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients. Cancer Lett 2003; 193:207-216.
15. Sozzi G, Conte D, Leon M, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003; 21:1-7.
16. Gal S, Fidler C, Lo YM, et al. Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR. Br J Cancer 2004; 90:1211-1215.
17. Palmisano VA, Divine M Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000; 60:5954-5958.
18. Jheon S, Hyun DS, Lee SC, et al. Lung cancer detection by a RT-nested PCR using MAGE A1-6 common primers. Lung Cancer 2004; 43:29-37.
19. Fiegl M, Haun M, Massoner A, et al. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/ mammaglobin B expression improves diagnosis of malignant effusions. J Clin Oncol 2004; 22:474-483.
20. Chan MH, Chow KM, Chan ATC, et al. Quantitative analysis of pleural fluid cell-free DNA as a tool for the classification of pleural effusions. Clin Chem 2003; 49:740-745.